Testosterone Undecanoate Drives Muscle Hypertrophy in Hypogonadal U.S. Men: Morphological Insights
Reading Time: 2 minutesIntroduction Testosterone deficiency, or hypogonadism, afflicts approximately 4-5 million American men, with prevalence escalating in those over 40 due to factors like obesity, metabolic syndrome, and sedentary lifestyles prevalent in the U.S. population. Testosterone undecanoate (TU), a long-acting intramuscular depot formulation, offers sustained androgen replacement therapy (ART) with dosing intervals of 10-14 weeks, minimizing peaks and troughs associated with shorter-acting... Read more »
